1. Home
  2. SRRK
  3. SRRK News

Latest Scholar Rock Holding Corporation (SRRK) News on August 2, 2025

SRRK

Business Wire

a month ago

Scholar Rock to Present Comprehensive Update at 2025 Annual Cure SMA Research and Clinical Care Meeting, Including Positive Results from Pivotal Phase 3 SAPPHIRE Trial

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says
SRRK

Reuters

a month ago

Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says

Scholar Rock (SRRK) Jumps 16.6% After Successful Weight Loss Drug Trial
SRRK

Insider Monkey

a month ago

Scholar Rock (SRRK) Jumps 16.6% After Successful Weight Loss Drug Trial

Why Scholar Rock Shares Are Soaring Today
SRRK

Motley Fool

a month ago

Why Scholar Rock Shares Are Soaring Today

Scholar Rock Stock Soars on Biopharma Firm's Weight-Loss Drug Trial Results
SRRK

Investopedia

a month ago

Scholar Rock Stock Soars on Biopharma Firm's Weight-Loss Drug Trial Results

SRRK

MT Newswires

a month ago

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

SRRK

MT Newswires

a month ago

Traders Eye Fed Decision, Driving Muted Premarket Action for US Equity Futures

SRRK

MT Newswires

a month ago

Sector Update: Health Care

SRRK

MT Newswires

a month ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Announcement Amid Geopolitical Tensions

SRRK

MT Newswires

a month ago

Scholar Rock Says Apitegromab With Tirzepatide Improves Weight Loss Quality in Phase 2 Trial

SRRK

MT Newswires

a month ago

Top Premarket Gainers

Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss
SRRK

Business Wire

a month ago

Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SRRK

Business Wire

2 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Exploring Three High Growth Tech Stocks In The US Market
SRRK

Simply Wall St.

2 months ago

Exploring Three High Growth Tech Stocks In The US Market

Scholar Rock to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
SRRK

Business Wire

2 months ago

Scholar Rock to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General Manager
SRRK

Business Wire

2 months ago

Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General Manager

Scholar Rock to Present at the Jefferies Global Healthcare Conference
SRRK

Business Wire

2 months ago

Scholar Rock to Present at the Jefferies Global Healthcare Conference

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SRRK

Business Wire

3 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock Holding Corp (SRRK) Q1 2025 Earnings Call Highlights: Strong Progress and ...
SRRK

GuruFocus.com

3 months ago

Scholar Rock Holding Corp (SRRK) Q1 2025 Earnings Call Highlights: Strong Progress and ...

SRRK

Thomson Reuters StreetEvents

3 months ago

Q1 2025 Scholar Rock Holding Corp Earnings Call

SRRK

MT Newswires

3 months ago

Scholar Rock's Q1 Net Loss Widens

Scholar Rock Reports First Quarter 2025 Financial Results and Highlights Business Progress
SRRK

Business Wire

3 months ago

Scholar Rock Reports First Quarter 2025 Financial Results and Highlights Business Progress

What To Expect From Scholar Rock Holding Corp (SRRK) Q1 2025 Earnings
SRRK

GuruFocus.com

3 months ago

What To Expect From Scholar Rock Holding Corp (SRRK) Q1 2025 Earnings

Scholar Rock to Host Conference Call to Discuss First Quarter 2025 Financial Results and Provide Business Update on May 14, 2025
SRRK

Business Wire

3 months ago

Scholar Rock to Host Conference Call to Discuss First Quarter 2025 Financial Results and Provide Business Update on May 14, 2025

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SRRK

Business Wire

3 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

US High Growth Tech Stocks To Watch
SRRK

Simply Wall St.

3 months ago

US High Growth Tech Stocks To Watch

Why Scholar Rock Stock Took a Knock on Monday
SRRK

Motley Fool

3 months ago

Why Scholar Rock Stock Took a Knock on Monday

SRRK

MT Newswires

3 months ago

Scholar Rock Names Chairman David Hallal as CEO

Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth
SRRK

Business Wire

3 months ago

Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth

Why Scholar Rock Holding Stock Topped the Market Today
SRRK

Motley Fool

3 months ago

Why Scholar Rock Holding Stock Topped the Market Today

Scholar Rock Holding Corp (SRRK) Q4 2024 Earnings Call Highlights: Clinical Success and ...
SRRK

GuruFocus.com

3 months ago

Scholar Rock Holding Corp (SRRK) Q4 2024 Earnings Call Highlights: Clinical Success and ...

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SRRK

Business Wire

3 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Exploring 3 High Growth Tech Stocks In The US Market
SRRK

Simply Wall St.

4 months ago

Exploring 3 High Growth Tech Stocks In The US Market

SRRK

MT Newswires

4 months ago

Scholar Rock Gets US FDA Priority Review for Potential Spinal Muscular Atrophy Treatment

FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy
SRRK

Business Wire

4 months ago

FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy

Scholar Rock SMA drug shows muscle function benefit
SRRK

Clinical Trials Arena

5 months ago

Scholar Rock SMA drug shows muscle function benefit

SRRK

MT Newswires

5 months ago

Scholar Rock Study of Potential Spinal Muscular Atrophy Treatment Meets Secondary Endpoints

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
SRRK

Business Wire

5 months ago

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SRRK

Business Wire

5 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRRK

MT Newswires

5 months ago

Scholar Rock Holding Insider Sold Shares Worth $5,068,974, According to a Recent SEC Filing

When Can We Expect A Profit From Scholar Rock Holding Corporation (NASDAQ:SRRK)?
SRRK

Simply Wall St.

5 months ago

When Can We Expect A Profit From Scholar Rock Holding Corporation (NASDAQ:SRRK)?

SRRK

Thomson Reuters StreetEvents

5 months ago

Q4 2024 Scholar Rock Holding Corp Earnings Call

SRRK

MT Newswires

5 months ago

Wedbush Adjusts Scholar Rock Price Target to $50 From $47, Maintains Outperform Rating

SRRK

MT Newswires

5 months ago

Scholar Rock's 2024 Loss Widens

Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress
SRRK

Business Wire

5 months ago

Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress

Earnings To Watch: Scholar Rock Holding Corp (SRRK) Reports Q4 2024 Result
SRRK

GuruFocus.com

5 months ago

Earnings To Watch: Scholar Rock Holding Corp (SRRK) Reports Q4 2024 Result

Scholar Rock to Participate in Upcoming Investor Conferences
SRRK

Business Wire

5 months ago

Scholar Rock to Participate in Upcoming Investor Conferences

Is Scholar Rock Holding (SRRK) One of the Oversold Biotech Stocks to Buy Now?
SRRK

Insider Monkey

5 months ago

Is Scholar Rock Holding (SRRK) One of the Oversold Biotech Stocks to Buy Now?

Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
SRRK

Business Wire

5 months ago

Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

SRRK

MT Newswires

5 months ago

Scholar Rock Holding Insider Sold Shares Worth $676,622, According to a Recent SEC Filing

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SRRK

Business Wire

6 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock to Host Conference Call to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Update on February 27, 2025
SRRK

Business Wire

6 months ago

Scholar Rock to Host Conference Call to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Update on February 27, 2025

SRRK

MT Newswires

6 months ago

Scholar Rock Files US FDA Application for Apitegromab in Spinal Muscular Atrophy

SRRK

MT Newswires

6 months ago

Scholar Rock Names Lisa Wyman as Chief Technical, Quality Officer, COO Role to Be Eliminated

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)
SRRK

Business Wire

6 months ago

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)

Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition
SRRK

Business Wire

6 months ago

Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition

SRRK

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 01/22/2025

SRRK

Business Wire

7 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here’s Why Scholar Rock Holding Corporation (SRRK) Is Skyrocketing
SRRK

Insider Monkey

7 months ago

Here’s Why Scholar Rock Holding Corporation (SRRK) Is Skyrocketing

SRRK

MT Newswires

7 months ago

Scholar Rock Plans Apitegromab Commercialization, Expanded Use in 2025

Scholar Rock Highlights 2025 Strategic Priorities
SRRK

Business Wire

7 months ago

Scholar Rock Highlights 2025 Strategic Priorities

Scholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SRRK

Business Wire

7 months ago

Scholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SRRK

Business Wire

8 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Why Is Scholar Rock Holding Corporation (SRRK) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
SRRK

Insider Monkey

8 months ago

Why Is Scholar Rock Holding Corporation (SRRK) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?

SRRK

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 11/29/2024

SRRK

MT Newswires

8 months ago

Top Midday Gainers

Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study
SRRK

Benzinga

8 months ago

Scholar Rock Stock Jumps As Rival Biohaven's Muscle-Wasting Drug Flunks Pivotal Study

SRRK

MT Newswires

8 months ago

Wedbush Raises Price Target on Scholar Rock to $47 From $40, Maintains Outperform Rating

SRRK

MT Newswires

8 months ago

Truist Securities Adjusts Price Target on Scholar Rock to $45 From $36, Maintains Buy Rating

Biohaven muscle drug misses goal of SMA study, but advances in obesity
SRRK

BioPharma Dive

8 months ago

Biohaven muscle drug misses goal of SMA study, but advances in obesity

SRRK

Business Wire

9 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
SRRK

GuruFocus.com

9 months ago

Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

SRRK

MT Newswires

9 months ago

Wedbush Raises Price Target on Scholar Rock to $40 From $37, Maintains Outperform Rating

SRRK

MT Newswires

9 months ago

Scholar Rock Holding Q3 Net Loss Widens

Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress
SRRK

Business Wire

9 months ago

Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress

Scholar Rock Holding Corp (SRRK) Q3 2024: Everything You Need To Know Ahead Of Earnings
SRRK

GuruFocus.com

9 months ago

Scholar Rock Holding Corp (SRRK) Q3 2024: Everything You Need To Know Ahead Of Earnings

Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin
SRRK

Business Wire

9 months ago

Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin

Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
SRRK

Business Wire

9 months ago

Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024

Scholar Rock to Participate in Upcoming Investor Conferences
SRRK

Business Wire

9 months ago

Scholar Rock to Participate in Upcoming Investor Conferences

Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting
SRRK

Business Wire

9 months ago

Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting

Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering
SRRK

Business Wire

9 months ago

Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering

Should You Buy Scholar Rock Holding Corporation (SRRK) After Golden Cross?
SRRK

Zacks

9 months ago

Should You Buy Scholar Rock Holding Corporation (SRRK) After Golden Cross?

SRRK

Business Wire

9 months ago

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PBF Energy, Gold Reserve, and More Stocks See Action From Activist Investors
SRRK

Barrons.com

10 months ago

PBF Energy, Gold Reserve, and More Stocks See Action From Activist Investors

Scholar Rock Holding Corp (SRRK) Q2 2024 Earnings Call Highlights: Advancing Key Milestones in ...
SRRK

GuruFocus.com

10 months ago

Scholar Rock Holding Corp (SRRK) Q2 2024 Earnings Call Highlights: Advancing Key Milestones in ...

Here's Why Everybody's Talking About Scholar Rock Right Now
SRRK

Motley Fool

10 months ago

Here's Why Everybody's Talking About Scholar Rock Right Now

SRRK

MT Newswires

10 months ago

Update: Scholar Rock Holding Prices Upsized $300 Million Public Offering

SRRK

MT Newswires

10 months ago

Scholar Rock Holding Prices Upsized $300 Million Public Offering

Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants
SRRK

Business Wire

10 months ago

Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants

SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal
SRRK

Zacks

10 months ago

SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal

Scholar Rock’s SMA Treatment Trials Show Promising Results
SRRK

TipRanks

10 months ago

Scholar Rock’s SMA Treatment Trials Show Promising Results

Scholar Rock's Spinal Muscular Atrophy Drug Plans for Children Under 2 Could Broaden Patient Group, Truist Says
SRRK

MT Newswires

10 months ago

Scholar Rock's Spinal Muscular Atrophy Drug Plans for Children Under 2 Could Broaden Patient Group, Truist Says

Scholar Rock stocks skyrocket after SMA drug scores at Phase III
SRRK

Clinical Trials Arena

10 months ago

Scholar Rock stocks skyrocket after SMA drug scores at Phase III

SRRK

MT Newswires

10 months ago

Scholar Rock Holding Insider Sold Shares Worth $2,976,468, According to a Recent SEC Filing

SRRK

MT Newswires

10 months ago

Scholar Rock Holding Insider Sold Shares Worth $5,477,546, According to a Recent SEC Filing

SRRK

MT Newswires

10 months ago

Scholar Rock Plans $275 Million Securities Sale

Scholar Rock Jumps 362% On Final-Phase Win In Spinal Muscular Atrophy
SRRK

Investor's Business Daily

10 months ago

Scholar Rock Jumps 362% On Final-Phase Win In Spinal Muscular Atrophy

Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
SRRK

Business Wire

10 months ago

Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Scholar Rock Shares Quadruple On Positive Drug-Study Results
SRRK

The Wall Street Journal

10 months ago

Scholar Rock Shares Quadruple On Positive Drug-Study Results

SRRK

MT Newswires

10 months ago

Top Midday Gainers

Share on Social Networks: